Tissues are the basic unit of function in the body, while cells are the building blocks of tissue. Extracellular matrix is a term used to describe the extracellular matrix, which is made and secreted by groups of cells. This matrix, or scaffold, serves as a relay station for many signaling molecules in addition to supporting the cells. As a result, cells get messages from a variety of sources that emerge from the immediate environment. Each signal can set off a series of events that determine the cell's fate. Researchers have been able to manage these processes to repair damaged tissues or even create new ones by studying how individual cells respond to signals, interact with their environment, and organize into tissues and organisms. Another way to make new tissue is to utilize a scaffold that already exists. The cells from a donor organ are removed, and the collagen scaffold that remains is used to generate new tissue. This method has been used to bioengineer tissue for the heart, liver, lungs, and kidneys. This method offers a lot of promise for employing scaffolding made from human tissue lost during surgery and mixing it with a patient's own cells to create tailored organs that the immune system won't reject.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy